Temporary circulatory support signals high risk in ascending aortic surgery

European Heart Journal Supplements

16 November 2026
Organised by: Logo
ESC Journals

Abstract

AbstractBackground

Ascending aortic surgery carries high perioperative risk, and device-specific outcomes of temporary mechanical circulatory support (MCS) is limited in this surgical population.

Objectives

To evaluate associations between temporary MCS strategies and in-hospital outcomes following ascending aortic surgery.

Methods

Adult hospitalizations undergoing ascending aortic or aortic arch replacement were identified using the 2019–2023 National Inpatient Sample. MCS was classified as none, intra-aortic balloon pump (IABP), temporary ventricular assist device (VAD), venoarterial extracorporeal membrane oxygenation (VA-ECMO), or multiple devices. Outcomes included mortality, stroke, acute kidney injury, and hospital charges. Survey-weighted multivariable regression adjusted for demographics, comorbidities, cardiogenic shock, mechanical ventilation, acute dissection, and concomitant cardiac procedures. The institutional review board determined this was not human-subjects research; informed consent was not required.

Results

Of 87 215 weighted hospitalizations involving ascending aortic surgery, 2705 (3.1%) involved temporary MCS. Compared with no MCS, each strategy was associated with higher adjusted odds of in-hospital mortality: IABP (adjusted odds ratio [aOR], 5.20; 95% CI, 3.65–7.40), VAD (aOR, 10.80; 95% CI, 5.29–22.06), VA-ECMO (aOR, 19.20; 95% CI, 11.61–31.75), and multiple devices (aOR, 21.89; 95% CI, 9.18–52.15). All strategies were associated with higher odds of acute kidney injury and higher hospital charges.

Conclusions

Temporary MCS during ascending aortic surgery was associated with higher in-hospital mortality, adverse events, and costs. These findings support selective, risk-based MCS use and underscore the need for further prospective studies distinguishing pre-emptive from rescue device placement.